SANGAMO THERAPEUTICS INC

The current price of GBY is 0.47 EUR — it has decreased by 4.69% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange SANGAMO THERAPEUTICS INC stocks are traded under the ticker GBY.

SANGAMO THERAPEUTICS INC is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.

GBY stock is 4.92% volatile and has beta coefficient of 1.54. Check out the list of the most volatile stocks — is SANGAMO THERAPEUTICS INC there?

GBY earnings for the last quarter are −0.56 EUR per share, whereas the estimation was −0.30 EUR resulting in a −85.03% surprise. The estimated earnings for the next quarter are −0.23 EUR per share. See more details about SANGAMO THERAPEUTICS INC earnings.

SANGAMO THERAPEUTICS INC revenue for the last quarter amounts to ‪8.89 M‬ EUR despite the estimated figure of ‪8.85 M‬ EUR. In the next quarter revenue is expected to reach ‪7.34 M‬ EUR.

Yes, you can track SANGAMO THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.

GBY stock has fallen by 9.24% compared to the previous week, the month change is a 31.32% fall, over the last year SANGAMO THERAPEUTICS INC has showed a 68.62% decrease.

Today SANGAMO THERAPEUTICS INC has the market capitalization of ‪99.17 M‬, it has decreased by 6.18% over the last week.

No, GBY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, GBY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANGAMO THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.

GBY reached its all-time high on Mar 7, 2018 with the price of 99.65 EUR, and its all-time low was 0.27 EUR and was reached on Nov 13, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 405.00 employees. See our rating of the largest employees — is SANGAMO THERAPEUTICS INC on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SANGAMO THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SANGAMO THERAPEUTICS INC stock shows the sell signal. See more of SANGAMO THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on SANGAMO THERAPEUTICS INC future price: according to them, GBY price has a max estimate of 7.36 EUR and a min estimate of 0.92 EUR. Read a more detailed SANGAMO THERAPEUTICS INC forecast: see what analysts think of SANGAMO THERAPEUTICS INC and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANGAMO THERAPEUTICS INC EBITDA is ‪−85.21 M‬ EUR, and current EBITDA margin is −52.26%. See more stats in SANGAMO THERAPEUTICS INC financial statements.